Task: Answer the multiple-choice question.
Query: Which drug exhibits a -26.169% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
[a] Cn1cccc1C(=O)NNC(=O)COc1ccc(Br)cc1
[b] COc1ccc(CCN2C(=O)CC(Cc3ccc(C)cc3)C2=O)cc1OC
Answer: b. COc1ccc(CCN2C(=O)CC(Cc3ccc(C)cc3)C2=O)cc1OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(CCN2C(=O)CC(Cc3ccc(C)cc3)C2=O)cc1OC
COc1ccc(CCN2C(=O)CC(Cc3ccc(C)cc3)C2=O)cc1OC
3-[(4-methylphenyl)methyl]-1-[2-(4,5-dimethoxyphenyl)ethyl]pyrrolidine-2,5-dione